Rhenman & Partners Asset Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-159,924
| Closed | -$1.37M | – | 98 |
|
|
2018
Q4 | $1.37M | Sell |
159,924
-113,669
| -42% | -$971K | 0.16% | 70 |
|
|
2018
Q3 | $5.48M | Sell |
273,593
-54,600
| -17% | -$1.09M | 0.55% | 61 |
|
|
2018
Q2 | $8.48M | Buy |
328,193
+118,549
| +57% | +$3.06M | 0.87% | 51 |
|
|
2018
Q1 | $5.01M | Sell |
209,644
-483,269
| -70% | -$11.5M | 0.62% | 55 |
|
|
2017
Q4 | $23.5M | Sell |
692,913
-222,087
| -24% | -$7.53M | 3.17% | 3 |
|
|
2017
Q3 | $19.4M | Buy |
915,000
+546,834
| +149% | +$11.6M | 2.47% | 10 |
|
|
2017
Q2 | $6.44M | Buy |
368,166
+213,166
| +138% | +$3.73M | 0.92% | 39 |
|
|
2017
Q1 | $2.71M | Buy |
155,000
+25,000
| +19% | +$438K | 0.43% | 74 |
|
|
2016
Q4 | $2.2M | Hold |
130,000
| – | – | 0.42% | 69 |
|
|
2016
Q3 | $2.13M | Hold |
130,000
| – | – | 0.34% | 78 |
|
|
2016
Q2 | $1.97M | Buy |
+130,000
| New | +$1.97M | 0.35% | 76 |
|